Artivion, Inc. (AORT)

CIK 0000784199 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-02-12) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-07) · 99.1
Q1-2025 8-K (2025-05-05) · 99.1
FY-2024 8-K (2025-02-24) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-06) · 99.1
FY-2023 8-K (2024-02-15) · 99.1
Q3-2023 8-K (2023-11-02) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Condensed Consolidated Statements of Operations and Comprehensive (loss) Income
—
Condensed Consolidated Statements of Operations and Comprehensive Income
—
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Operations and Comprehensive Income (loss)
Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statements of Stockholders' Equity
—
Consolidated Statements of Shareholders' Equity
Notes
(loss) Income Per Common Share
—
Acquisition of Ascyrus
Acquisition of Endospan
—
Agreements With Endospan
Basis of Presentation and Summary of Significant Accounting Policies
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Employee Benefit Plans
—
Financial Instruments
Goodwill and Other Intangible Assets
Income (loss) Per Common Share
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories and Deferred Preservation Costs
Inventories and Deferred Preservation Costs, Net
—
Inventories, Net and Deferred Preservation Costs
—
Leases
Loss Per Common Share
Pay Vs Performance Disclosure
Revenue Recognition
Sale of Perclot
Segment and Geographic Information
—
Segment Information
—
Stock Compensation
Subsequent Events